This company is no longer active
Pharmiva (PHARM) Stock Overview
Pharmiva AB (publ) engages in the research and development of medical products in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
PHARM Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Pharmiva AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.56 |
| 52 Week High | SEK 2.74 |
| 52 Week Low | SEK 0.56 |
| Beta | 1.56 |
| 1 Month Change | -39.52% |
| 3 Month Change | -31.03% |
| 1 Year Change | -61.11% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -94.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHARM | SE Pharmaceuticals | SE Market | |
|---|---|---|---|
| 7D | -20.0% | -3.4% | -1.5% |
| 1Y | -61.1% | -24.2% | 10.5% |
Return vs Industry: PHARM underperformed the Swedish Pharmaceuticals industry which returned 28.5% over the past year.
Return vs Market: PHARM underperformed the Swedish Market which returned 5.8% over the past year.
Price Volatility
| PHARM volatility | |
|---|---|
| PHARM Average Weekly Movement | 20.2% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 12.6% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: PHARM's share price has been volatile over the past 3 months.
Volatility Over Time: PHARM's weekly volatility has increased from 14% to 20% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 5 | Anna Linton | www.pharmiva.com |
Pharmiva AB (publ) engages in the research and development of medical products in Sweden. The company offers Vernivia, an over-the-counter vaginal mousse for the treatment of bacterial vaginosis. The company was incorporated in 2015 and is headquartered in Lund, Sweden.
Pharmiva AB (publ) Fundamentals Summary
| PHARM fundamental statistics | |
|---|---|
| Market cap | SEK 9.73m |
| Earnings (TTM) | -SEK 21.42m |
| Revenue (TTM) | SEK 4.26m |
Is PHARM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHARM income statement (TTM) | |
|---|---|
| Revenue | SEK 4.26m |
| Cost of Revenue | SEK 1.65m |
| Gross Profit | SEK 2.61m |
| Other Expenses | SEK 24.03m |
| Earnings | -SEK 21.42m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.23 |
| Gross Margin | 61.22% |
| Net Profit Margin | -502.51% |
| Debt/Equity Ratio | 0% |
How did PHARM perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/11/21 12:28 |
| End of Day Share Price | 2023/11/17 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Pharmiva AB (publ) is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Niklas Elmhammer | Carlsquare AB |